Skip to main content

Medications for Ventricular Tachycardia

Other names: Tachycardia, Ventricular; V-tach; VT

Ventricular tachycardia is a rapid heart beat initiated within the ventricles, characterized by 3 or more consecutive premature ventricular beats.

Drugs used to treat Ventricular Tachycardia

The following list of medications are in some way related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
atenolol Off-label 7.5 15 reviews for atenolol to treat Ventricular Tachycardia
Rx D N X

Generic name: atenolol systemic

Drug class: cardioselective beta blockers

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Off-label: Yes

amiodarone 6.5 19 reviews for amiodarone to treat Ventricular Tachycardia
Rx D N

Generic name: amiodarone systemic

Brand names:  Pacerone, Nexterone

Drug class: group III antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

propranolol Off-label 7.3 4 reviews for propranolol to treat Ventricular Tachycardia
Rx C N X

Generic name: propranolol systemic

Drug class: non-cardioselective beta blockers, group II antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Off-label: Yes

flecainide 7.6 17 reviews for flecainide to treat Ventricular Tachycardia
Rx C N

Generic name: flecainide systemic

Brand name:  Tambocor

Drug class: group I antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

mexiletine 5.5 2 reviews for mexiletine to treat Ventricular Tachycardia
Rx C N

Generic name: mexiletine systemic

Drug class: group I antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

propafenone 8.0 6 reviews for propafenone to treat Ventricular Tachycardia
Rx C N

Generic name: propafenone systemic

Brand name:  Rythmol SR

Drug class: group I antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

lidocaine Rate Add review
Rx B N

Generic name: lidocaine systemic

Brand names:  Xylocaine-MPF, Xylocaine HCl, DentiPatch

Drug class: local injectable anesthetics, group I antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Pacerone 0.0 1 review for Pacerone to treat Ventricular Tachycardia
Rx D N

Generic name: amiodarone systemic

Drug class: group III antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Tambocor 7.0 3 reviews for Tambocor to treat Ventricular Tachycardia
Rx C N

Generic name: flecainide systemic

Drug class: group I antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

acebutolol Off-label Rate Add review
Rx B N X

Generic name: acebutolol systemic

Drug class: cardioselective beta blockers, group II antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Off-label: Yes

Nexterone Rate Add review
Rx D N

Generic name: amiodarone systemic

Drug class: group III antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

vasopressin Rate Add review
Rx C N

Generic name: vasopressin systemic

Brand name:  Vasostrict

Drug class: antidiuretic hormones

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Rythmol SR 6.5 2 reviews for Rythmol SR to treat Ventricular Tachycardia
Rx C N

Generic name: propafenone systemic

Drug class: group I antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Xylocaine-MPF Rate Add review
Rx B N

Generic name: lidocaine systemic

Drug class: local injectable anesthetics, group I antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Xylocaine HCl Rate Add review
Rx B N

Generic name: lidocaine systemic

Drug class: local injectable anesthetics, group I antiarrhythmics

For consumers: dosage, interactions, side effects

DentiPatch Rate Add review
Rx B N

Generic name: lidocaine systemic

Drug class: local injectable anesthetics, group I antiarrhythmics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Vasostrict Rate Add review
Rx C N

Generic name: vasopressin systemic

Drug class: antidiuretic hormones

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Frequently asked questions

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.